-
WHO issues alert for falsified COVID-19 vaccine
europeanpharmaceuticalreview
March 30, 2021
The World Health Organization (WHO) has warned that a falsified COVID-19 vaccine, identified as Pfizer’s BNT162b2, could still be in circulation in the Americas.
-
WHO statement on AstraZeneca COVID-19 vaccine safety signals
worldpharmanews
March 22, 2021
Some countries in the European Union have temporarily suspended use of the AstraZeneca COVID-19 vaccine as a precautionary measure based on reports of rare blood coagulation disorders in persons who had received the vaccine.
-
Vardhman Health Specialities forays into Adult Immunisation
expresspharma
March 19, 2021
Vardhman Health Specialities (VHS Group), a WHO certified pharma distribution company and a leader in specialty pharma and healthcare supply chain, announced its foray into ‘Adult Immunisation’ and its plans to grow this as a distinct category and ...
-
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria
prnasia
March 15, 2021
SuperTrans Medical has announced the appointment of three Australian companies to play pivotal roles in an upcoming clinical drug trial that offers new hope in the plight against antimicrobial resistance (AMR), which the World Health Organisation ...
-
J&J single-shot COVID-19 vaccine gets Emergency Use Listing by WHO
expresspharma
March 15, 2021
Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including those with variants of significant concern.
-
AstraZeneca Advances Mass Global Rollout of COVID-19 Vaccine through COVAX
americanpharmaceuticalreview
March 08, 2021
The first of AstraZeneca’s COVID-19 vaccine have begun arriving in low and middle-income countries across the world through the multilateral COVAX initiative, the first steps in fulfilling the Company’s efforts to provide broad and equitable access to ...
-
WHO panel advises against use of hydroxychloroquine to prevent Covid-19
pharmaceutical-technology
March 03, 2021
The World Health Organization’s (WHO) Guideline Development Group (GDG) expert panel has made a recommendation against the use of the anti-inflammatory drug hydroxychloroquine to prevent Covid-19.
-
WHO chief scientist says India exhibited capacity to innovate, manufacture vaccines
expresspharma
March 03, 2021
India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization’s Chief Scientist Soumya Swaminathan said Monday.
-
Hoarding of COVID-19 vaccines are threatening global supply via COVAX: WHO
expresspharma
March 01, 2021
WHO is one of the leaders of COVAX, a programme that aims to supply 1.3 billion vaccine doses to poor and middle income countries this year.
-
J&J Announces Single-Shot Janssen COVID-19 Vaccine Candidate Submission to WHO
americanpharmaceuticalreview
February 23, 2021
Johnson & Johnson announced Janssen-Cilag International has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate.